The CRI is pleased to announce a new collaborative project with Elligo Health Research in which both teams will assist the US Food and Drug Administration (FDA) with developing a standard common data model to guide evidence generation in biomedical research studiesand bridge clinical research and clinical care. As part of a grant awarded by the Patient Centered Outcomes Research (PCOR) Trust Fund, the FDA is currently involved in an effort to harmonize multiple common data models and open standards. By mapping data from disparate sources to one consensus-based model, the project will facilitate interoperability between data networks and make new research possible.
The CRI’s rich Clinical Research Data Warehouse and experience in the development and maintenance of data models make us a natural partner for Elligo and the FDA in developing and implementing interoperability standards. In addition to providing the FDA with valuable information about the safety of new cancer treatments, this project will help assess the value of the standard common data model for real world evidence research, as well as the tools and methods used to achieve the data harmonization. Learn more about what we’ll be working on here.
